Research Paper Volume 12, Issue 10 pp 9188—9204

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy

class="figure-viewer-img"

Figure 3. Prognostic value of DElncRNAs in predicting LGG patient PFS after radiotherapy.